This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2012 May 10;30(14):1584-7.

doi: 10.1200/JCO.2011.39.9980. Epub 2012 Feb 27.

A way forward on the medically appropriate use of white cell growth factors

Thomas J Smith¹, Bruce E Hillner

Affiliations

PMID: 22370327
PMCID: PMC3383110
DOI: 10.1200/JCO.2011.39.9980

Review

A way forward on the medically appropriate use of white cell growth factors

Thomas J Smith et al. J Clin Oncol. 2012.

. 2012 May 10;30(14):1584-7.

doi: 10.1200/JCO.2011.39.9980. Epub 2012 Feb 27.

Authors

Thomas J Smith¹, Bruce E Hillner

Affiliation

¹ Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287-0005, USA. tsmit136@jhmi.edu

PMID: 22370327
PMCID: PMC3383110
DOI: 10.1200/JCO.2011.39.9980

No abstract available

PubMed Disclaimer

Similar articles

The role of mini-allotransplants in the treatment of solid tumors.
Schouten HC. Schouten HC. Ann Oncol. 2002;13 Suppl 4:281-6. doi: 10.1093/annonc/mdf671. Ann Oncol. 2002. PMID: 12401702 Review. No abstract available.
High-dose chemotherapy for breast cancer.
Nieto Y, Shpall EJ. Nieto Y, et al. Cancer Treat Res. 2000;103:77-114. doi: 10.1007/978-1-4757-3147-7_5. Cancer Treat Res. 2000. PMID: 10948443 Review. No abstract available.
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
Johnston LJ, Stockerl-Goldstein KE, Hu WW, Negrin RS, Hoppe RT, Blume KG, Horning SJ. Johnston LJ, et al. Biol Blood Marrow Transplant. 2000;6(5A):555-62. doi: 10.1016/s1083-8791(00)70065-6. Biol Blood Marrow Transplant. 2000. PMID: 11071261
Abskopale Effekte nach Strahlentherapie in Kombination mit GM-CSF : Revolutionärer Paradigmenwechsel oder Sturm im Wasserglas?
Zschaeck S, Baumann M. Zschaeck S, et al. Strahlenther Onkol. 2016 Sep;192(9):675-6. doi: 10.1007/s00066-016-1017-5. Strahlenther Onkol. 2016. PMID: 27402387 German. No abstract available.
Status of high-dose chemotherapy for breast cancer: a review.
Nieto Y, Champlin RE, Wingard JR, Vredenburgh JF, Elias AD, Richardson P, Glaspy J, Jones RB, Stiff PJ, Bearman SI, Cagnoni PJ, McSweeney PA, LeMaistre CF, Pecora AL, Shpall EF. Nieto Y, et al. Biol Blood Marrow Transplant. 2000;6(5):476-95. doi: 10.1016/s1083-8791(00)70019-x. Biol Blood Marrow Transplant. 2000. PMID: 11063377 Review.

See all similar articles

Cited by

Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy--a representative sample survey in Germany.
Link H, Nietsch J, Kerkmann M, Ortner P; Supportive Care Group (ASORS) of the German Cancer Society (DKG). Link H, et al. Support Care Cancer. 2016 Jan;24(1):367-376. doi: 10.1007/s00520-015-2779-5. Epub 2015 Jun 17. Support Care Cancer. 2016. PMID: 26081593
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis.
Weycker D, Barron R, Edelsberg J, Kartashov A, Legg J, Glass AG. Weycker D, et al. BMC Health Serv Res. 2014 Apr 27;14:189. doi: 10.1186/1472-6963-14-189. BMC Health Serv Res. 2014. PMID: 24767095 Free PMC article.
Practice Patterns for Older Adult Patients With Advanced Cancer: Physician Office Versus Hospital Outpatient Setting.
Lipitz-Snyderman A, Atoria CL, Schleicher SM, Bach PB, Panageas KS. Lipitz-Snyderman A, et al. J Oncol Pract. 2019 Jan;15(1):e30-e38. doi: 10.1200/JOP.18.00315. Epub 2018 Dec 13. J Oncol Pract. 2019. PMID: 30543762 Free PMC article.
Patterns of granulocyte colony-stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy.
Gawade PL, Li S, Henry D, Smith N, Belani R, Kelsh MA, Bradbury BD. Gawade PL, et al. Support Care Cancer. 2020 Sep;28(9):4413-4424. doi: 10.1007/s00520-020-05295-2. Epub 2020 Jan 10. Support Care Cancer. 2020. PMID: 31919669 Free PMC article.

References

1. Smith TJ, Hillner BE. Bending the cost curve in cancer care. N Engl J Med. 2011;364:2060–2065. - PMC - PubMed
1. Potosky AL, Malin JL, Kim B, et al. Use of colony-stimulating factors with chemotherapy: Opportunities for cost savings and improved outcomes. J Natl Cancer Inst. 2011;103:979–982. - PMC - PubMed
1. Ozer H, Armitage JO, Bennett CL, et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. J Clin Oncol. 2000;18:3558–3585. - PubMed
1. Smith TJ, Khatcheressian J, Lyman GH, et al. 2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol. 2006;24:3187–3205. - PubMed
1. NCCN clinical practice guidelines in oncology. Myeloid growth factors: Version 1. 2011. http://www.nci.net.pk/Guidelines/Myeloid%20Growth%20Factors.doc. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources